The University of MichiganNews Services
The University Record Online
search
Updated 10:00 AM April 17, 2006
 

front

accolades

briefs

view events

submit events

UM employment


obituaries
police beat
regents round-up
research reporter
letters


archives

Advertise with Record

contact us
meet the staff
contact us
contact us

  Research
Peek at 'birth' of cell may help fight eye disease

Scientists at the Kellogg Eye Center have gained new insight into the way an embryonic retina cell develops and commits itself to a specific role. The discovery provides a new vantage point for understanding how a healthy visual system develops, and also raises the possibility of redirecting the production of cell types to stave off eye disease.

The study—in which researchers observed a small window of opportunity when a cell has been designated to play a particular role, but has not yet begun to function as such—reports on the role of the gene regulator NRL, which previously was shown to be essential for the development of rods, the light-sensing cells required for vision.

Anand Swaroop, the Harold F. Falls Collegiate Professor of Ophthalmology and Visual Sciences and professor of human genetics, is senior author of the study, which appeared in the March 7 issue of the Proceedings of the National Academy of Sciences.

Swaroop and his team report that NRL is the earliest marker of rod precursors, or cells that are fated to become rods. They achieved this unique and early view of rod development by creating a mouse model using an NRL regulatory DNA sequence to produce a protein that appears as fluorescent green when exposed to blue light. This protein allows scientists to identify even a few cells that are destined to be rods at very early stages of development.

"For the first time we were able to see retina cells during early development, allowing us to pinpoint the exact time at which rods are 'born,'" Swaroop says. "Because the cells have been tagged, we can watch them at each step as they develop into mature and functional rods." Kellogg scientists purified the rods at various stages and generated the profile of genes at each stage. This provided a handle for investigating the precise process of rod differentiation.

Rods, along with cones, are photoreceptors that account for 70 percent to 80 percent of all cells in the adult retina. Rods greatly outnumber cones in mice and humans. Damage to photoreceptors is at the root of eye diseases such as diabetic retinopathy, retinitis pigmentosa and macular degeneration. In most instances rods die before cones.

As the mouse eye develops, rods start out as stem cells, meaning they have not yet been assigned a function and could grow to become any kind of cell. Along the way, these cells change gene expression and acquire competence to become a specific cell type. At a certain point cell division stops and the cell is committed to a specific function.

"We can now view rod precursor cells at a crucial juncture," Swaroop says. "They are committed to becoming rod cells, but they are still adaptable and have not yet become that type of cell." In mouse models, it takes 5-14 days for rod cells to become functional; in humans the period is 4-5 weeks during gestation.

The Swaroop research team also confirmed that when NRL is absent, a rod precursor will change its course and acquire the identity of a cone. "This finding in particular implies the existence of pools of progenitor cells with competence to become either a rod or a cone," Swaroop says. "We suggest that during early stages of development these cells are not completely committed to a specific fate; there is an opportunity for regulators such as NRL to instruct these cells to produce rods or cones."

With the ability to see greater detail in events along molecular pathways, Swaroop is enthusiastic about finding new methods for disrupting the disease process. There also may be opportunities to promote the production of new rods and cones when others die.

In future studies, Swaroop plans to use this new model in conjunction with other mouse models of specific diseases, such as macular and other retinal degenerations. Gene profiling of rods and cones in disease models at various stages of pathogenesis could help scientists identify molecular targets for drug treatment.

Swaroop is hopeful that his research group can use the fluorescent protein to illuminate the chain of events that occurs when a gene mutation interferes with rod or cone development. "This model may give us the earliest look yet at some devastating diseases we are all eager to cure," Swaroop says.

More Stories